Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andrew R Mack

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Antimicrobial agents and chemotherapy

mBio

eLife

PloS one

Case Western Reserve University

Case Western Reserve University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Case Western Reserve University Jul 10o 2017

United States

PhD Student :: Molecular Biology and Microbiology

Education History

Case Western Reserve University

United States

PHD :: Molecular Biology and Microbiology

Publications

Andrew R Mack, Vijay Kumar, Magdalena A Taracila, María Fernanda Mojica, Margaret O'Shea, William Schinabeck, Galen Silver, Andrea M Hujer, Krisztina M Papp-Wallace, Shuang Chen, Shozeb M Haider, Emilia Caselli, Fabio Prati, Focco van den Akker, Robert A Bonomo
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase. Antimicrobial agents and chemotherapy (2023)
Andrea M Hujer, Steven H Marshall, Andrew R Mack, Kristine M Hujer, Yamuna Devi Bakthavatchalam, Kushal Umarkar, Snehal R Palwe, Swapna Takalkar, Prashant R Joshi, Rahul Shrivastava, Hariharan Periasamy, Sachin S Bhagwat, Mahesh V Patel, Veeraraghavan Balaji, Robert A Bonomo
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam. mBio (2023)
Andrea M Hujer, Christopher R Bethel, Magdalena A Taracila, Steven H Marshall, Laura J Rojas, Marisa L Winkler, Ronald E Painter, T Nicholas Domitrovic, Richard R Watkins, Ayman M Abdelhamed, Roshan D'Souza, Andrew R Mack, Richard C White, Thomas Clarke, Derrick E Fouts, Michael R Jacobs, Katherine Young, Robert A Bonomo
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance. Antimicrobial agents and chemotherapy 66 (5) (2022)
Laura J Rojas, Mohamad Yasmin, Jacquelynn Benjamino, Steven M Marshall, Kailynn J DeRonde, Nikhil P Krishnan, Federico Perez, Andrew A Colin, Monica Cardenas, Octavio Martinez, Armando Pérez-Cardona, Daniel D Rhoads, Michael R Jacobs, John J LiPuma, Michael W Konstan, Alejandro J Vila, Andrea Smania, Andrew R Mack, Jacob G Scott, Mark D Adams, Lilian M Abbo, Robert A Bonomo
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing. PloS one 17 (3) (2022)
Ioannis Galdadas, Shen Qu, Ana Sofia F Oliveira, Edgar Olehnovics, Andrew R Mack, Maria F Mojica, Pratul K Agarwal, Catherine L Tooke, Francesco Luigi Gervasio, James Spencer, Robert A Bonomo, Adrian J Mulholland, Shozeb M Haider
Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics. eLife 10 (2021)
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Gabriel Cabot, Michael Feldgarden, Daniel H Haft, William Klimke, Focco van den Akker, Alejandro J Vila, Andrea Smania, Shozeb Haider, Krisztina M Papp-Wallace, Patricia A Bradford, Gian Maria Rossolini, Jean-Denis Docquier, Jean-Marie Frère, Moreno Galleni, Nancy D Hanson, Antonio Oliver, Patrick Plésiat, Laurent Poirel, Patrice Nordmann, Timothy G Palzkill, George A Jacoby, Karen Bush, Robert A Bonomo
A Standard Numbering Scheme for Class C β-Lactamases. Antimicrobial agents and chemotherapy 64 (3) (2020)

Andrew R Mack.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew R Mack